Redmile Group, LLC - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Silence Therapeutics plc

Filing Manager: Redmile Group, LLC
Reporting Manager: Redmile Group, LLC
Security: Silence Therapeutics plc Ordinary Shares, nominal value GBP 0.05 per share
Shares outstanding: 141M shares
Disclosed Ownership: 7.2M shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 08:03 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Redmile Group, LLC	5.1%	7.2M	0	7.2M	/s/ Jeremy C. Green	Managing Member
Jeremy C. Green	5.1%	7.2M	0	7.2M	/s/ Jeremy C. Green	Jeremy C. Green